PapersFlow Research Brief
Cerebrovascular and genetic disorders
Research Guide
What is Cerebrovascular and genetic disorders?
Cerebrovascular and genetic disorders refer to hereditary small vessel diseases like CADASIL, caused by Notch3 receptor mutations, leading to cerebrovascular dysfunction, white matter lesions, cognitive impairment, and strokes.
This field centers on Cerebral Autosomal Dominant Arteriopathy with Subcortical Infarcts and Leukoencephalopathy (CADASIL), a genetic disorder involving Notch3 mutations that cause recurrent strokes and dementia. There are 16,920 papers in this cluster with a focus on genetics, clinical features, diagnosis, pathogenesis, and management. Key aspects include MRI hyperintensities, microbleeds, and HtrA1 mutations in small vessel disease.
Topic Hierarchy
Research Sub-Topics
Notch3 Mutations in CADASIL Pathogenesis
This sub-topic investigates the functional consequences of Notch3 gene mutations on vascular smooth muscle cells and endothelial dysfunction. Researchers study genotype-phenotype correlations, protein aggregation, and animal models of mutant Notch3 expression.
Neuroimaging Biomarkers in CADASIL
This sub-topic focuses on MRI techniques to quantify white matter hyperintensities, lacunar infarcts, and microbleeds as progression markers. Researchers develop automated segmentation algorithms and longitudinal studies correlating imaging with clinical decline.
Cognitive Impairment in CADASIL Patients
This sub-topic examines neuropsychological profiles, executive dysfunction, and progression to subcortical dementia in CADASIL. Researchers explore correlations with lesion load, genetic modifiers, and interventions to preserve cognition.
Clinical Diagnosis and Management of CADASIL
This sub-topic covers diagnostic criteria, genetic testing protocols, and symptomatic treatments for stroke prevention and migraine. Researchers assess antiplatelet therapy efficacy, blood pressure control, and multidisciplinary care models.
Granular Osmiophilic Material in CADASIL
This sub-topic analyzes the ultrastructural pathology of granular osmiophilic material (GOM) in skin and brain biopsies as a diagnostic hallmark. Researchers investigate GOM composition, formation mechanisms, and its absence in Notch3 mutation-negative cases.
Why It Matters
CADASIL demonstrates how genetic mutations in the Notch3 receptor produce adult-onset strokes and progressive dementia, informing diagnosis and potential therapies for hereditary cerebrovascular diseases. Joutel et al. (1996) identified Notch3 mutations as the cause of CADASIL, enabling genetic testing that confirms diagnosis in symptomatic patients with family history. Pantoni (2010) outlined pathogenesis and clinical traits of cerebral small vessel disease, highlighting challenges in treatment that affect thousands with white matter lesions and cognitive decline. Wardlaw et al. (2013) established neuroimaging standards for small vessel disease research, standardizing MRI assessment of hyperintensities and microbleeds to track progression in aging populations. These advances support clinical management in neurology, reducing misdiagnosis of vascular contributions to dementia as seen in Román et al. (1993) criteria for vascular dementia.
Reading Guide
Where to Start
"Notch3 mutations in CADASIL, a hereditary adult-onset condition causing stroke and dementia" by Joutel et al. (1996) because it provides the foundational genetic discovery of CADASIL with clear links to clinical symptoms.
Key Papers Explained
Joutel et al. (1996) "Notch3 mutations in CADASIL, a hereditary adult-onset condition causing stroke and dementia" established the genetic basis with Notch3 mutations. Schroeter et al. (1998) "Notch-1 signalling requires ligand-induced proteolytic release of intracellular domain" explained Notch signaling mechanisms relevant to CADASIL pathology. Pantoni (2010) "Cerebral small vessel disease: from pathogenesis and clinical characteristics to therapeutic challenges" built on this by detailing small vessel disease features overlapping with CADASIL. Wardlaw et al. (2013) "Neuroimaging standards for research into small vessel disease and its contribution to ageing and neurodegeneration" provided tools to study progression. Gorelick et al. (2011) "Vascular Contributions to Cognitive Impairment and Dementia" connected vascular genetics to broader dementia impacts.
Paper Timeline
Most-cited paper highlighted in red. Papers ordered chronologically.
Advanced Directions
Research emphasizes refining MRI biomarkers for early CADASIL detection and exploring HtrA1 mutations alongside Notch3 in small vessel disease models. Current work builds on Wardlaw et al. (2013) standards and Pantoni (2010) challenges to address therapeutic gaps in genetic cerebrovascular disorders.
Papers at a Glance
| # | Paper | Year | Venue | Citations | Open Access |
|---|---|---|---|---|---|
| 1 | Beneficial Effect of Carotid Endarterectomy in Symptomatic Pat... | 1991 | New England Journal of... | 8.4K | ✓ |
| 2 | Neuroimaging standards for research into small vessel disease ... | 2013 | The Lancet Neurology | 5.2K | ✓ |
| 3 | Vascular dementia | 1993 | Neurology | 4.9K | ✕ |
| 4 | Mild cognitive impairment | 2006 | The Lancet | 3.8K | ✕ |
| 5 | [17] Amylases, α and β | 1955 | Methods in enzymology ... | 3.7K | ✕ |
| 6 | Vascular Contributions to Cognitive Impairment and Dementia | 2011 | Stroke | 3.6K | ✓ |
| 7 | Cerebral small vessel disease: from pathogenesis and clinical ... | 2010 | The Lancet Neurology | 3.3K | ✕ |
| 8 | Notch3 mutations in CADASIL, a hereditary adult-onset conditio... | 1996 | Nature | 2.0K | ✕ |
| 9 | The Pathobiology of Vascular Dementia | 2013 | Neuron | 1.7K | ✓ |
| 10 | Notch-1 signalling requires ligand-induced proteolytic release... | 1998 | Nature | 1.6K | ✕ |
Frequently Asked Questions
What is CADASIL?
CADASIL is Cerebral Autosomal Dominant Arteriopathy with Subcortical Infarcts and Leukoencephalopathy, a hereditary small vessel disease caused by Notch3 mutations. It leads to recurrent strokes, white matter lesions, and cognitive impairment. Joutel et al. (1996) first described these mutations in patients with stroke and dementia.
How are Notch3 mutations involved in CADASIL?
Notch3 mutations disrupt receptor signaling in vascular smooth muscle cells, causing small vessel pathology. Joutel et al. (1996) linked these mutations to the hereditary condition producing strokes and dementia. This genetic defect results in granular osmiophilic material accumulation in vessel walls.
What role does neuroimaging play in small vessel disease?
Neuroimaging standards enable research into small vessel disease contributions to aging and neurodegeneration. Wardlaw et al. (2013) defined protocols for assessing white matter hyperintensities and microbleeds via MRI. These standards improve detection of cerebrovascular changes in CADASIL and related disorders.
What are clinical features of cerebral small vessel disease?
Cerebral small vessel disease presents with lacunar infarcts, white matter lesions, cognitive impairment, and gait disturbances. Pantoni (2010) detailed its pathogenesis, characteristics, and therapeutic challenges. It often progresses to vascular dementia with subcortical involvement.
How do vascular factors contribute to cognitive impairment?
Vascular contributions include small vessel disease leading to infarcts and hypoperfusion affecting cognition. Gorelick et al. (2011) overviewed evidence for vascular cognitive impairment definitions and neuropathology. This is prevalent in later life, overlapping with CADASIL features like those from Notch3 mutations.
Open Research Questions
- ? How do Notch3 mutations precisely disrupt vascular signaling to cause white matter lesions and cognitive decline?
- ? What therapeutic targets emerge from Notch3 and HtrA1 mutation pathways in CADASIL?
- ? How can neuroimaging biomarkers predict stroke risk and progression in genetic small vessel diseases?
- ? What are the long-term outcomes of cognitive impairment in CADASIL patients with identified Notch3 variants?
Recent Trends
The field maintains 16,920 works on CADASIL and related genetic small vessel diseases, with steady focus on Notch3 mutations as in Joutel et al.
1996Emphasis persists on neuroimaging standards from Wardlaw et al. and small vessel pathogenesis per Pantoni (2010), without new preprints or news in the last 12 months.
2013Research Cerebrovascular and genetic disorders with AI
PapersFlow provides specialized AI tools for Medicine researchers. Here are the most relevant for this topic:
Systematic Review
AI-powered evidence synthesis with documented search strategies
AI Literature Review
Automate paper discovery and synthesis across 474M+ papers
Find Disagreement
Discover conflicting findings and counter-evidence
Paper Summarizer
Get structured summaries of any paper in seconds
See how researchers in Health & Medicine use PapersFlow
Field-specific workflows, example queries, and use cases.
Start Researching Cerebrovascular and genetic disorders with AI
Search 474M+ papers, run AI-powered literature reviews, and write with integrated citations — all in one workspace.
See how PapersFlow works for Medicine researchers